{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T13:02:03Z","timestamp":1789563723441,"version":"build-2803163510"},"reference-count":223,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T00:00:00Z","timestamp":1783296000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1038\/s41581-026-01096-8","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T14:02:45Z","timestamp":1783346565000},"page":"704-720","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Metabolic determinants of autoimmune kidney diseases"],"prefix":"10.1038","volume":"22","author":[{"given":"Yogesh","family":"Scindia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6622-1290","authenticated-orcid":false,"given":"Laurence","family":"Morel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,6]]},"reference":[{"key":"1096_CR1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1242454","volume":"342","author":"EL Pearce","year":"2013","unstructured":"Pearce, E. L., Poffenberger, M. C., Chang, C. H. & Jones, R. G. Fueling immunity: insights into metabolism and lymphocyte function. Science 342, 1242454 (2013).","journal-title":"Science"},{"key":"1096_CR2","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1038\/nature11862","volume":"493","author":"LA O\u2019Neill","year":"2013","unstructured":"O\u2019Neill, L. A. & Hardie, D. G. Metabolism of inflammation limited by AMPK and pseudo-starvation. Nature 493, 346\u2013355 (2013).","journal-title":"Nature"},{"key":"1096_CR3","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.it.2023.01.002","volume":"44","author":"L Soriano-Baguet","year":"2023","unstructured":"Soriano-Baguet, L. & Brenner, D. Metabolism and epigenetics at the heart of T cell function. Trends Immunol. 44, 231\u2013244 (2023).","journal-title":"Trends Immunol."},{"key":"1096_CR4","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1111\/imr.12847","volume":"295","author":"X Teng","year":"2020","unstructured":"Teng, X., Brown, J., Choi, S. C., Li, W. & Morel, L. Metabolic determinants of lupus pathogenesis. Immunol. Rev. 295, 167\u2013186 (2020).","journal-title":"Immunol. Rev."},{"key":"1096_CR5","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1007\/s11926-022-01063-9","volume":"24","author":"PM Chen","year":"2022","unstructured":"Chen, P. M. & Tsokos, G. C. Mitochondria in the pathogenesis of systemic lupus erythematosus. Curr. Rheumatol. Rep. 24, 88\u201395 (2022).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1096_CR6","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2024.109939","author":"MM Furment","year":"2024","unstructured":"Furment, M. M. & Perl, A. Immmunometabolism of systemic lupus erythematosus. Clin. Immunol. https:\/\/doi.org\/10.1016\/j.clim.2024.109939 (2024).","journal-title":"Clin. Immunol."},{"key":"1096_CR7","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1038\/s41584-025-01267-0","volume":"21","author":"E Pati\u00f1o-Martinez","year":"2025","unstructured":"Pati\u00f1o-Martinez, E. & Kaplan, M. J. Immunometabolism in systemic lupus erythematosus. Nat. Rev. Rheumatol. 21, 377\u2013395 (2025).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1096_CR8","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-45080-x","volume":"15","author":"M Scherlinger","year":"2024","unstructured":"Scherlinger, M. et al. CaMK4 controls follicular helper T cell expansion and function during normal and autoimmune T-dependent B cell responses. Nat. Commun. 15, 840 (2024).","journal-title":"Nat. Commun."},{"key":"1096_CR9","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adp4447","volume":"17","author":"W Li","year":"2025","unstructured":"Li, W. et al. Gluconolactone restores immune regulation and alleviates skin inflammation in lupus-prone mice and in patients with cutaneous lupus. Sci. Transl. Med. 17, eadp4447 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR10","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1097\/BOR.0000000000000089","volume":"26","author":"N Schwartz","year":"2014","unstructured":"Schwartz, N., Goilav, B. & Putterman, C. The pathogenesis, diagnosis and treatment of lupus nephritis. Curr. Opin. Rheumatol. 26, 502\u2013509 (2014).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1096_CR11","doi-asserted-by":"publisher","first-page":"v39","DOI":"10.1093\/rheumatology\/keaa381","volume":"59","author":"M Gasparotto","year":"2020","unstructured":"Gasparotto, M., Gatto, M., Binda, V., Doria, A. & Moroni, G. Lupus nephritis: clinical presentations and outcomes in the 21st century. Rheumatology 59, v39\u2013v51 (2020).","journal-title":"Rheumatology"},{"key":"1096_CR12","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1038\/nm.2752","volume":"18","author":"Z Liu","year":"2012","unstructured":"Liu, Z. & Davidson, A. Taming lupus \u2014 a new understanding of pathogenesis is leading to clinical advances. Nat. Med. 18, 871\u2013882 (2012).","journal-title":"Nat. Med."},{"key":"1096_CR13","doi-asserted-by":"publisher","first-page":"255","DOI":"10.1038\/s41584-020-0401-9","volume":"16","author":"NI Maria","year":"2020","unstructured":"Maria, N. I. & Davidson, A. Protecting the kidney in systemic lupus erythematosus: from diagnosis to therapy. Nat. Rev. Rheumatol. 16, 255\u2013267 (2020).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1096_CR14","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2024.103535","volume":"23","author":"M Bruschi","year":"2024","unstructured":"Bruschi, M. et al. A critical view on autoantibodies in lupus nephritis: concrete knowledge based on evidence. Autoimmun. Rev. 23, 103535 (2024).","journal-title":"Autoimmun. Rev."},{"key":"1096_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41572-025-00653-y","volume":"11","author":"I Parodis","year":"2025","unstructured":"Parodis, I. et al. Lupus nephritis. Nat. Rev. Dis. Primers 11, 69 (2025).","journal-title":"Nat. Rev. Dis. Primers"},{"key":"1096_CR16","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.clim.2016.09.012","volume":"185","author":"T Iwamoto","year":"2017","unstructured":"Iwamoto, T. & Niewold, T. B. Genetics of human lupus nephritis. Clin. Immunol. 185, 32\u201339 (2017).","journal-title":"Clin. Immunol."},{"key":"1096_CR17","doi-asserted-by":"publisher","first-page":"1369","DOI":"10.1681\/ASN.V1271369","volume":"12","author":"GP Lema","year":"2001","unstructured":"Lema, G. P. et al. Chemokine expression precedes inflammatory cell infiltration and chemokine receptor and cytokine expression during the initiation of murine lupus nephritis. J. Am. Soc. Nephrol. 12, 1369\u20131382 (2001).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR18","doi-asserted-by":"publisher","first-page":"491","DOI":"10.1038\/s41581-023-00722-z","volume":"19","author":"C Mohan","year":"2023","unstructured":"Mohan, C., Zhang, T. & Putterman, C. Pathogenic cellular and molecular mediators in lupus nephritis. Nat. Rev. Nephrol. 19, 491\u2013508 (2023).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR19","doi-asserted-by":"publisher","first-page":"3359","DOI":"10.1002\/art.38888","volume":"66","author":"AJ Kinloch","year":"2014","unstructured":"Kinloch, A. J. et al. Vimentin is a dominant target of in situ humoral immunity in human lupus tubulointerstitial nephritis. Arthritis Rheumatol. 66, 3359\u20133370 (2014).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR20","doi-asserted-by":"publisher","first-page":"2483","DOI":"10.1681\/ASN.2013090987","volume":"25","author":"M Bruschi","year":"2014","unstructured":"Bruschi, M. et al. Glomerular autoimmune multicomponents of human lupus nephritis in vivo: \u03b1-enolase and annexin AI. J. Am. Soc. Nephrol. 25, 2483\u20132498 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR21","doi-asserted-by":"publisher","first-page":"404","DOI":"10.1016\/S0140-6736(06)69114-9","volume":"368","author":"X Bosch","year":"2006","unstructured":"Bosch, X., Guilabert, A. & Font, J. Antineutrophil cytoplasmic antibodies. Lancet 368, 404\u2013418 (2006).","journal-title":"Lancet"},{"key":"1096_CR22","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1038\/nrmicro1710","volume":"5","author":"V Brinkmann","year":"2007","unstructured":"Brinkmann, V. & Zychlinsky, A. Beneficial suicide: why neutrophils die to make NETs. Nat. Rev. Microbiol. 5, 577\u2013582 (2007).","journal-title":"Nat. Rev. Microbiol."},{"key":"1096_CR23","doi-asserted-by":"publisher","first-page":"9813","DOI":"10.1073\/pnas.0909927107","volume":"107","author":"A Hakkim","year":"2010","unstructured":"Hakkim, A. et al. Impairment of neutrophil extracellular trap degradation is associated with lupus nephritis. Proc. Natl Acad. Sci. USA 107, 9813\u20139818 (2010).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR24","first-page":"43","volume":"20","author":"SA Chalmers","year":"2015","unstructured":"Chalmers, S. A., Chitu, V., Ramanujam, M. & Putterman, C. Therapeutic targeting of macrophages in lupus nephritis. Discov. Med. 20, 43\u201349 (2015).","journal-title":"Discov. Med."},{"key":"1096_CR25","doi-asserted-by":"publisher","DOI":"10.1126\/sciimmunol.abf7777","volume":"7","author":"SA Dick","year":"2022","unstructured":"Dick, S. A. et al. Three tissue resident macrophage subsets coexist across organs with conserved origins and life cycles. Sci. Immunol. 7, eabf7777 (2022).","journal-title":"Sci. Immunol."},{"key":"1096_CR26","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-16158-z","volume":"11","author":"F Liu","year":"2020","unstructured":"Liu, F. et al. Distinct fate, dynamics and niches of renal macrophages of bone marrow or embryonic origins. Nat. Commun. 11, 2280 (2020).","journal-title":"Nat. Commun."},{"key":"1096_CR27","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.125503","volume":"4","author":"JM Lever","year":"2019","unstructured":"Lever, J. M. et al. Resident macrophages reprogram toward a developmental state after acute kidney injury. JCI Insight 4, e125503 (2019).","journal-title":"JCI Insight"},{"key":"1096_CR28","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.159751","volume":"7","author":"N Richoz","year":"2022","unstructured":"Richoz, N. et al. Distinct pathogenic roles for resident and monocyte-derived macrophages in lupus nephritis. JCI Insight 7, e159751 (2022).","journal-title":"JCI Insight"},{"key":"1096_CR29","doi-asserted-by":"publisher","first-page":"820","DOI":"10.1038\/ki.2010.13","volume":"77","author":"F Yu","year":"2010","unstructured":"Yu, F. et al. Tubulointerstitial lesions of patients with lupus nephritis classified by the 2003 International Society of Nephrology and Renal Pathology Society system. Kidney Intern. 77, 820\u2013829 (2010).","journal-title":"Kidney Intern."},{"key":"1096_CR30","doi-asserted-by":"publisher","first-page":"3281","DOI":"10.1681\/ASN.2004110917","volume":"16","author":"S Yung","year":"2005","unstructured":"Yung, S., Tsang, R. C., Sun, Y., Leung, J. K. & Chan, T. M. Effect of human anti-DNA antibodies on proximal renal tubular epithelial cell cytokine expression: implications on tubulointerstitial inflammation in lupus nephritis. J. Am. Soc. Nephrol. 16, 3281\u20133294 (2005).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR31","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1093\/ckj\/sfx093","volume":"11","author":"PC Wilson","year":"2018","unstructured":"Wilson, P. C., Kashgarian, M. & Moeckel, G. Interstitial inflammation and interstitial fibrosis and tubular atrophy predict renal survival in lupus nephritis. Clin. Kidney J. 11, 207\u2013218 (2018).","journal-title":"Clin. Kidney J."},{"key":"1096_CR32","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2020.578952","volume":"11","author":"S Hong","year":"2020","unstructured":"Hong, S., Healy, H. & Kassianos, A. J. The emerging role of renal tubular epithelial cells in the immunological pathophysiology of lupus nephritis. Front. Immunol. 11, 578952 (2020).","journal-title":"Front. Immunol."},{"key":"1096_CR33","doi-asserted-by":"publisher","first-page":"1136","DOI":"10.1016\/j.immuni.2020.11.006","volume":"53","author":"RA Elsner","year":"2020","unstructured":"Elsner, R. A. & Shlomchik, M. J. Germinal center and extrafollicular B cell responses in vaccination, immunity, and autoimmunity. Immunity 53, 1136\u20131150 (2020).","journal-title":"Immunity"},{"key":"1096_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2025.103433","volume":"154","author":"QY Su","year":"2025","unstructured":"Su, Q. Y. et al. The role of age-associated B cells in systemic lupus erythematosus. J. Autoimmun. 154, 103433 (2025).","journal-title":"J. Autoimmun."},{"key":"1096_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2022.110912","volume":"39","author":"S Urbanczyk","year":"2022","unstructured":"Urbanczyk, S. et al. Mitochondrial respiration in B lymphocytes is essential for humoral immunity by controlling the flux of the TCA cycle. Cell Rep. 39, 110912 (2022).","journal-title":"Cell Rep."},{"key":"1096_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2024.113739","volume":"43","author":"TEH Bierling","year":"2024","unstructured":"Bierling, T. E. H. et al. GLUT1-mediated glucose import in B cells is critical for anaplerotic balance and humoral immunity. Cell Rep. 43, 113739 (2024).","journal-title":"Cell Rep."},{"key":"1096_CR37","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1038\/s41590-020-0598-4","volume":"21","author":"FJ Weisel","year":"2020","unstructured":"Weisel, F. J. et al. Germinal center B cells selectively oxidize fatty acids for energy while conducting minimal glycolysis. Nat. Immunol. 21, 331\u2013342 (2020).","journal-title":"Nat. Immunol."},{"key":"1096_CR38","doi-asserted-by":"publisher","first-page":"3626","DOI":"10.4049\/jimmunol.1302062","volume":"192","author":"A Caro-Maldonado","year":"2014","unstructured":"Caro-Maldonado, A. et al. Metabolic reprogramming is required for antibody production that is suppressed in anergic but exaggerated in chronically BAFF-exposed B cells. J. Immunol. 192, 3626\u20133636 (2014).","journal-title":"J. Immunol."},{"key":"1096_CR39","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.4049\/jimmunol.2100356","volume":"208","author":"SC Choi","year":"2022","unstructured":"Choi, S. C. et al. Pharmacologically inferred glycolysis and glutaminolysis requirement of B cells in lupus-prone mice. J. Immunol. 208, 2098\u20132108 (2022).","journal-title":"J. Immunol."},{"key":"1096_CR40","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54941-4","volume":"15","author":"S Wang","year":"2024","unstructured":"Wang, S. et al. Aberrant METTL1-mediated tRNA m7G modification alters B-cell responses in systemic autoimmunity in humans and mice. Nat. Commun. 15, 10599 (2024).","journal-title":"Nat. Commun."},{"key":"1096_CR41","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-018-06686-0","volume":"9","author":"SC Choi","year":"2018","unstructured":"Choi, S. C. et al. Inhibition of glucose metabolism selectively targets autoreactive follicular helper T cells. Nat. Commun. 9, 4369 (2018).","journal-title":"Nat. Commun."},{"key":"1096_CR42","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1038\/nri1957","volume":"6","author":"A Marshak-Rothstein","year":"2006","unstructured":"Marshak-Rothstein, A. Toll-like receptors in systemic autoimmune disease. Nat. Rev. Immunol. 6, 823\u2013835 (2006).","journal-title":"Nat. Rev. Immunol."},{"key":"1096_CR43","doi-asserted-by":"publisher","first-page":"377","DOI":"10.4049\/jimmunol.2200325","volume":"210","author":"G Abboud","year":"2023","unstructured":"Abboud, G. et al. Glucose requirement of antigen-specific autoreactive B cells and CD4+ T cells. J. Immunol. 210, 377\u2013388 (2023).","journal-title":"J. Immunol."},{"key":"1096_CR44","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20221346","volume":"220","author":"KM Nickerson","year":"2023","unstructured":"Nickerson, K. M. et al. Age-associated B cells are heterogeneous and dynamic drivers of autoimmunity in mice. J. Exp. Med. 220, e20221346 (2023).","journal-title":"J. Exp. Med."},{"key":"1096_CR45","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1002\/art.42433","volume":"75","author":"X Han","year":"2023","unstructured":"Han, X. et al. Amelioration of autoimmunity in a lupus mouse model by modulation of T-Bet-promoted energy metabolism in pathogenic age\/autoimmune-associated B cells. Arthritis Rheumatol. 75, 1203\u20131215 (2023).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR46","doi-asserted-by":"publisher","first-page":"60","DOI":"10.1016\/j.immuni.2016.06.011","volume":"45","author":"WY Lam","year":"2016","unstructured":"Lam, W. Y. et al. Mitochondrial pyruvate import promotes long-term survival of antibody-secreting plasma cells. Immunity 45, 60\u201373 (2016).","journal-title":"Immunity"},{"key":"1096_CR47","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1002\/art.43200","volume":"77","author":"R Bhargava","year":"2025","unstructured":"Bhargava, R. et al. Aberrant glycosylation of IgG in children with active lupus nephritis alters podocyte metabolism and causes podocyte injury. Arthritis Rheumatol. 77, 1421\u20131432 (2025).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1038\/nrneph.2016.20","volume":"12","author":"F Hiepe","year":"2016","unstructured":"Hiepe, F. & Radbruch, A. Plasma cells as an innovative target in autoimmune disease with renal manifestations. Nat. Rev. Nephrol. 12, 232\u2013240 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR49","doi-asserted-by":"publisher","first-page":"1496","DOI":"10.1038\/s12276-020-00504-8","volume":"52","author":"HC Yoo","year":"2020","unstructured":"Yoo, H. C., Yu, Y. C., Sung, Y. & Han, J. M. Glutamine reliance in cell metabolism. Exp. Mol. Med. 52, 1496\u20131516 (2020).","journal-title":"Exp. Mol. Med."},{"key":"1096_CR50","doi-asserted-by":"publisher","first-page":"274ra18","DOI":"10.1126\/scitranslmed.aaa0835","volume":"7","author":"Y Yin","year":"2015","unstructured":"Yin, Y. et al. Normalization of CD4+ T cell metabolism reverses lupus. Sci. Transl. Med. 7, 274ra18 (2015).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.116600","volume":"44","author":"SC Choi","year":"2025","unstructured":"Choi, S. C. et al. Glycolysis inhibition functionally reprograms T follicular helper cells and reverses lupus. Cell Rep. 44, 116600 (2025).","journal-title":"Cell Rep."},{"key":"1096_CR52","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.imlet.2022.03.008","volume":"247","author":"X Zou","year":"2022","unstructured":"Zou, X. et al. Metabolic regulation of follicular helper T cell differentiation in a mouse model of lupus. Immunol. Lett. 247, 13\u201321 (2022).","journal-title":"Immunol. Lett."},{"key":"1096_CR53","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.189858","volume":"10","author":"V Kim","year":"2025","unstructured":"Kim, V. et al. Metabolic pathways within cTfh subsets and glucose-dependent activation of cTfh17 in SLE and healthy individuals. JCI Insight 10, e189858 (2025).","journal-title":"JCI Insight"},{"key":"1096_CR54","doi-asserted-by":"publisher","first-page":"1869","DOI":"10.1002\/art.41019","volume":"71","author":"M Kono","year":"2019","unstructured":"Kono, M. et al. Glutaminase 1 inhibition reduces glycolysis and ameliorates lupus-like disease in MRL\/lpr mice and experimental autoimmune encephalomyelitis. Arthritis Rheumatol. 71, 1869\u20131878 (2019).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR55","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.192286","volume":"10","author":"SC Choi","year":"2025","unstructured":"Choi, S. C. et al. Intrinsic T cell glutaminolysis promotes autoimmunity in lupus-prone mice. JCI Insight 10, e192286 (2025).","journal-title":"JCI Insight"},{"key":"1096_CR56","doi-asserted-by":"publisher","first-page":"1971","DOI":"10.1002\/art.42284","volume":"74","author":"LP Blanco","year":"2022","unstructured":"Blanco, L. P. et al. Modulation of the itaconate pathway attenuates murine lupus. Arthritis Rheumatol, 74, 1971\u20131983 (2022).","journal-title":"Arthritis Rheumatol,"},{"key":"1096_CR57","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36594-x","volume":"14","author":"K Aso","year":"2023","unstructured":"Aso, K. et al. Itaconate ameliorates autoimmunity by modulating T cell imbalance via metabolic and epigenetic reprogramming. Nat. Commun. 14, 984 (2023).","journal-title":"Nat. Commun."},{"key":"1096_CR58","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1038\/nm.4027","volume":"22","author":"C Lood","year":"2016","unstructured":"Lood, C. et al. Neutrophil extracellular traps enriched in oxidized mitochondrial DNA are interferogenic and contribute to lupus-like disease. Nat. Med. 22, 146\u2013153 (2016).","journal-title":"Nat. Med."},{"key":"1096_CR59","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1084\/jem.20151876","volume":"213","author":"S Caielli","year":"2016","unstructured":"Caielli, S. et al. Oxidized mitochondrial nucleoids released by neutrophils drive type I interferon production in human lupus. J. Exp. Med. 213, 697\u2013713 (2016).","journal-title":"J. Exp. Med."},{"key":"1096_CR60","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aav5928","volume":"13","author":"I Melki","year":"2021","unstructured":"Melki, I. et al. Platelets release mitochondrial antigens in systemic lupus erythematosus. Sci. Transl. Med. 13, eaav5928 (2021).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR61","doi-asserted-by":"publisher","first-page":"4464","DOI":"10.1016\/j.cell.2021.07.021","volume":"184","author":"S Caielli","year":"2021","unstructured":"Caielli, S. et al. Erythroid mitochondrial retention triggers myeloid-dependent type I interferon in human SLE. Cell 184, 4464\u20134479 (2021).","journal-title":"Cell"},{"key":"1096_CR62","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1080\/08830180490452576","volume":"23","author":"A Perl","year":"2004","unstructured":"Perl, A., Gergely, P. Jr. & Banki, K. Mitochondrial dysfunction in T cells of patients with systemic lupus erythematosus. Int. Rev. Immunol. 23, 293\u2013313 (2004).","journal-title":"Int. Rev. Immunol."},{"key":"1096_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.celrep.2025.115851","volume":"44","author":"H Ji","year":"2025","unstructured":"Ji, H. et al. ENPP1 governs the metabolic regulation of effector T cells in autoimmunity by detecting cytosolic mitochondrial DNA. Cell Rep. 44, 115851 (2025).","journal-title":"Cell Rep."},{"key":"1096_CR64","doi-asserted-by":"publisher","first-page":"388","DOI":"10.3899\/jrheum.210391","volume":"49","author":"T Iwamoto","year":"2022","unstructured":"Iwamoto, T. et al. High systemic type I interferon activity is associated with active class III\/IV lupus nephritis. J. Rheumatol. 49, 388\u2013397 (2022).","journal-title":"J. Rheumatol."},{"key":"1096_CR65","doi-asserted-by":"publisher","first-page":"3190","DOI":"10.1002\/art.39296","volume":"67","author":"H Wang","year":"2015","unstructured":"Wang, H., Li, T., Chen, S., Gu, Y. & Ye, S. Neutrophil extracellular trap mitochondrial DNA and its autoantibody in systemic lupus erythematosus and a proof-of-concept trial of metformin. Arthritis Rheumatol. 67, 3190\u20133200 (2015).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR66","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1016\/j.ard.2025.11.007","volume":"85","author":"YLC Becker","year":"2025","unstructured":"Becker, Y. L. C. et al. Antimitochondrial antibodies in systemic lupus erythematosus are associated with and predict nephritis, arterial vascular events, and mortality. Ann. Rheum. Dis. 85, 659\u2013668 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR67","doi-asserted-by":"publisher","first-page":"1026","DOI":"10.3389\/fimmu.2019.01026","volume":"10","author":"Y Becker","year":"2019","unstructured":"Becker, Y. et al. Autoantibodies in systemic lupus erythematosus target mitochondrial RNA. Front. Immunol. 10, 1026 (2019).","journal-title":"Front. Immunol."},{"key":"1096_CR68","doi-asserted-by":"publisher","first-page":"5096","DOI":"10.1093\/rheumatology\/keaf275","volume":"64","author":"MB Mac\u00eado","year":"2025","unstructured":"Mac\u00eado, M. B. et al. Anti-mitochondrial antibodies as markers of disease activity in childhood-onset systemic lupus erythematosus: a longitudinal cohort study. Rheumatology 64, 5096\u20135100 (2025).","journal-title":"Rheumatology"},{"key":"1096_CR69","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1177\/09612033241247622","volume":"33","author":"S Gowda","year":"2024","unstructured":"Gowda, S. et al. Extracellular mitochondrial components as new biomarkers for lupus nephritis. Lupus 33, 779\u2013786 (2024).","journal-title":"Lupus"},{"key":"1096_CR70","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25116162","volume":"25","author":"M Halfon","year":"2024","unstructured":"Halfon, M., Tankeu, A. T. & Ribi, C. Mitochondrial dysfunction in systemic lupus erythematosus with a focus on lupus nephritis. Int. J. Mol. Sci. 25, 6162 (2024).","journal-title":"Int. J. Mol. Sci."},{"key":"1096_CR71","doi-asserted-by":"publisher","first-page":"4884","DOI":"10.1172\/JCI120859","volume":"128","author":"JS Tilstra","year":"2018","unstructured":"Tilstra, J. S. et al. Kidney-infiltrating T cells in murine lupus nephritis are metabolically and functionally exhausted. J. Clin. Invest. 128, 4884\u20134897 (2018).","journal-title":"J. Clin. Invest."},{"key":"1096_CR72","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-41353-z","volume":"14","author":"GA Heieis","year":"2023","unstructured":"Heieis, G. A. et al. Metabolic heterogeneity of tissue-resident macrophages in homeostasis and during helminth infection. Nat. Commun. 14, 5627 (2023).","journal-title":"Nat. Commun."},{"key":"1096_CR73","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.aay1620","volume":"12","author":"PM Chen","year":"2020","unstructured":"Chen, P. M. et al. Kidney tissue hypoxia dictates T cell-mediated injury in murine lupus nephritis. Sci. Transl. Med. 12, eaay1620 (2020).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR74","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adf8156","volume":"9","author":"I Chernova","year":"2023","unstructured":"Chernova, I. et al. The ion transporter Na+-K+-ATPase enables pathological B cell survival in the kidney microenvironment of lupus nephritis. Sci. Adv. 9, eadf8156 (2023).","journal-title":"Sci. Adv."},{"key":"1096_CR75","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-021-93034-w","volume":"11","author":"KM Kingsmore","year":"2021","unstructured":"Kingsmore, K. M. et al. Altered expression of genes controlling metabolism characterizes the tissue response to immune injury in lupus. Sci. Rep. 11, 14789 (2021).","journal-title":"Sci. Rep."},{"key":"1096_CR76","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1113\/JP280572","volume":"599","author":"SJ Kierans","year":"2021","unstructured":"Kierans, S. J. & Taylor, C. T. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J. Physiol. 599, 23\u201337 (2021).","journal-title":"J. Physiol."},{"key":"1096_CR77","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1097\/BOR.0000000000000577","volume":"31","author":"H Nishi","year":"2019","unstructured":"Nishi, H. & Mayadas, T. N. Neutrophils in lupus nephritis. Curr. Opin. Rheumatol. 31, 193\u2013200 (2019).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1096_CR78","doi-asserted-by":"publisher","first-page":"240","DOI":"10.1681\/ASN.20233411S1240c","volume":"34","author":"BH Rovin","year":"2023","unstructured":"Rovin, B. H. et al. Evaluation of intrarenal plasmacytoid dendritic cells in active lupus nephritis. J. Am. Soc. Nephrol. 34, 240\u2013241 (2023).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR79","doi-asserted-by":"publisher","DOI":"10.1172\/JCI169893","volume":"134","author":"A Tambralli","year":"2024","unstructured":"Tambralli, A. et al. Neutrophil glucose flux as a therapeutic target in antiphospholipid syndrome. J. Clin. Invest. 134, e169893 (2024).","journal-title":"J. Clin. Invest."},{"key":"1096_CR80","doi-asserted-by":"publisher","first-page":"454","DOI":"10.1002\/art.41128","volume":"72","author":"LP Blanco","year":"2020","unstructured":"Blanco, L. P. et al. Improved mitochondrial metabolism and reduced inflammation following attenuation of murine lupus with coenzyme Q10 analog idebenone. Arthritis Rheumatol. 72, 454\u2013464 (2020).","journal-title":"Arthritis Rheumatol."},{"key":"1096_CR81","doi-asserted-by":"publisher","first-page":"15160","DOI":"10.1073\/pnas.2000943117","volume":"117","author":"C Jing","year":"2020","unstructured":"Jing, C. et al. Macrophage metabolic reprogramming presents a therapeutic target in lupus nephritis. Proc. Natl Acad. Sci. USA 117, 15160\u201315171 (2020).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR82","doi-asserted-by":"publisher","first-page":"771","DOI":"10.1038\/cr.2015.68","volume":"25","author":"B Kelly","year":"2015","unstructured":"Kelly, B. & O\u2019Neill, L. A. J. Metabolic reprogramming in macrophages and dendritic cells in innate immunity. Cell Res. 25, 771\u2013784 (2015).","journal-title":"Cell Res."},{"key":"1096_CR83","doi-asserted-by":"publisher","DOI":"10.1084\/jem.20241873","volume":"222","author":"PJ Hoover","year":"2025","unstructured":"Hoover, P. J. et al. A human-mouse atlas of intrarenal myeloid cells identifies conserved disease-associated macrophages in lupus nephritis. J. Exp. Med. 222, e2024187 (2025).","journal-title":"J. Exp. Med."},{"key":"1096_CR84","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.621039","volume":"12","author":"SV Parikh","year":"2021","unstructured":"Parikh, S. V. et al. A novel inflammatory dendritic cell that is abundant and contiguous to T cells in the kidneys of patients with lupus nephritis. Front. Immunol. 12, 621039 (2021).","journal-title":"Front. Immunol."},{"key":"1096_CR85","doi-asserted-by":"publisher","first-page":"608","DOI":"10.1136\/ard-2023-224788","volume":"83","author":"W Chen","year":"2024","unstructured":"Chen, W. et al. Single-cell profiling reveals kidney CD163+ dendritic cell participation in human lupus nephritis. Ann. Rheum. Dis. 83, 608\u2013623 (2024).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR86","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1140749","volume":"14","author":"L Wu","year":"2023","unstructured":"Wu, L. et al. Metabolic regulation of dendritic cell activation and immune function during inflammation. Front. Immunol. 14, 1140749 (2023).","journal-title":"Front. Immunol."},{"key":"1096_CR87","doi-asserted-by":"publisher","first-page":"1498","DOI":"10.1136\/annrheumdis-2018-213615","volume":"77","author":"K Ma","year":"2018","unstructured":"Ma, K. et al. TLR4+CXCR4+ plasma cells drive nephritis development in systemic lupus erythematosus. Ann. Rheum. Dis. 77, 1498\u20131506 (2018).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR88","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adu6015","volume":"17","author":"Q Zeng","year":"2025","unstructured":"Zeng, Q. et al. The m6A demethylase FTO links TLR7 to mitochondrial oxidation driving age-associated B cell formation in systemic lupus erythematosus. Sci. Transl. Med. 17, eadu6015 (2025).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR89","doi-asserted-by":"publisher","first-page":"881","DOI":"10.1038\/s41423-023-01049-2","volume":"20","author":"K Ma","year":"2023","unstructured":"Ma, K. et al. B1-cell-produced anti-phosphatidylserine antibodies contribute to lupus nephritis development via TLR-mediated Syk activation. Cell Mol. Immunol. 20, 881\u2013894 (2023).","journal-title":"Cell Mol. Immunol."},{"key":"1096_CR90","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1084\/jem.20170771","volume":"215","author":"AJ Clarke","year":"2018","unstructured":"Clarke, A. J., Riffelmacher, T., Braas, D., Cornall, R. J. & Simon, A. K. B1a B cells require autophagy for metabolic homeostasis and self-renewal. J. Exp. Med. 215, 399\u2013413 (2018).","journal-title":"J. Exp. Med."},{"key":"1096_CR91","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107122","volume":"26","author":"AS Elshikha","year":"2023","unstructured":"Elshikha, A. S. et al. Pharmacologic inhibition of glycolysis prevents the development of lupus by altering the gut microbiome in mice. iScience 26, 107122 (2023).","journal-title":"iScience"},{"key":"1096_CR92","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-42625-4","volume":"14","author":"O Suchanek","year":"2023","unstructured":"Suchanek, O. et al. Tissue-resident B cells orchestrate macrophage polarisation and function. Nat. Commun. 14, 7081 (2023).","journal-title":"Nat. Commun."},{"key":"1096_CR93","doi-asserted-by":"publisher","first-page":"545","DOI":"10.1016\/j.semarthrit.2017.07.007","volume":"47","author":"A Broder","year":"2018","unstructured":"Broder, A. et al. Tubulointerstitial damage predicts end stage renal disease in lupus nephritis with preserved to moderately impaired renal function: a retrospective cohort study. Semin. Arthritis Rheum. 47, 545\u2013551 (2018).","journal-title":"Semin. Arthritis Rheum."},{"key":"1096_CR94","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1038\/s41586-021-03442-1","volume":"593","author":"BI Reinfeld","year":"2021","unstructured":"Reinfeld, B. I. et al. Cell-programmed nutrient partitioning in the tumour microenvironment. Nature 593, 282\u2013288 (2021).","journal-title":"Nature"},{"key":"1096_CR95","doi-asserted-by":"publisher","DOI":"10.1080\/08916934.2025.2582720","volume":"58","author":"J Qing","year":"2025","unstructured":"Qing, J. et al. Single-cell transcriptomic analysis reveals T cell heterogeneity and metabolic reprogramming in human immune-mediated glomerulonephritis. Autoimmunity 58, 2582720 (2025).","journal-title":"Autoimmunity"},{"key":"1096_CR96","doi-asserted-by":"publisher","first-page":"902","DOI":"10.1038\/s41590-019-0398-x","volume":"20","author":"A Arazi","year":"2019","unstructured":"Arazi, A. et al. The immune cell landscape in kidneys of patients with lupus nephritis. Nat. Immunol. 20, 902\u2013914 (2019).","journal-title":"Nat. Immunol."},{"key":"1096_CR97","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1097\/BOR.0000000000000815","volume":"33","author":"PM Chen","year":"2021","unstructured":"Chen, P. M. & Tsokos, G. C. The role of CD8+ T-cell systemic lupus erythematosus pathogenesis: an update. Curr. Opin. Rheumatol. 33, 586\u2013591 (2021).","journal-title":"Curr. Opin. Rheumatol."},{"key":"1096_CR98","doi-asserted-by":"publisher","first-page":"112","DOI":"10.1016\/j.celrep.2019.12.014","volume":"30","author":"E Katsuyama","year":"2020","unstructured":"Katsuyama, E. et al. The CD38\/NAD\/SIRTUIN1\/EZH2 axis mitigates cytotoxic CD8 T cell function and identifies patients with SLE prone to infections. Cell Rep. 30, 112\u2013123 (2020).","journal-title":"Cell Rep."},{"key":"1096_CR99","doi-asserted-by":"publisher","DOI":"10.1172\/JCI142428","volume":"131","author":"H Li","year":"2021","unstructured":"Li, H. et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J. Clin. Invest. 131, e142428 (2021).","journal-title":"J. Clin. Invest."},{"key":"1096_CR100","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.654912","volume":"8","author":"FC Paquissi","year":"2021","unstructured":"Paquissi, F. C. & Abensur, H. The Th17\/IL-17 axis and kidney diseases, with focus on lupus nephritis. Front. Med. 8, 654912 (2021).","journal-title":"Front. Med."},{"key":"1096_CR101","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.20110278","volume":"208","author":"LZ Shi","year":"2011","unstructured":"Shi, L. Z. et al. HIF1\u03b1-dependent glycolytic pathway orchestrates a metabolic checkpoint for the differentiation of TH17 and Treg cells. J. Exp. Med. 208, 1367\u20131376 (2011).","journal-title":"J. Exp. Med."},{"key":"1096_CR102","doi-asserted-by":"publisher","first-page":"2478","DOI":"10.1073\/pnas.1714717115","volume":"115","author":"M Kono","year":"2018","unstructured":"Kono, M., Yoshida, N., Maeda, K. & Tsokos, G. C. Transcriptional factor ICER promotes glutaminolysis and the generation of Th17 cells. Proc. Natl Acad. Sci. USA 115, 2478\u20132483 (2018).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR103","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1038\/nm.3704","volume":"20","author":"L Berod","year":"2014","unstructured":"Berod, L. et al. De novo fatty acid synthesis controls the fate between regulatory T and T helper 17 cells. Nat. Med. 20, 1327\u20131333 (2014).","journal-title":"Nat. Med."},{"key":"1096_CR104","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaut.2022.102870","volume":"132","author":"H Li","year":"2022","unstructured":"Li, H., Boulougoura, A., Endo, Y. & Tsokos, G. C. Abnormalities of T cells in systemic lupus erythematosus: new insights in pathogenesis and therapeutic strategies. J. Autoimmun. 132, 102870 (2022).","journal-title":"J. Autoimmun."},{"key":"1096_CR105","doi-asserted-by":"publisher","DOI":"10.1016\/j.autrev.2025.103910","volume":"24","author":"D Michailidou","year":"2025","unstructured":"Michailidou, D., Gartshteyn, Y., Askanase, A. D. & Perl, A. The role of mTOR signaling pathway in systemic lupus erythematosus and systemic vasculitis. Autoimmun. Rev. 24, 103910 (2025).","journal-title":"Autoimmun. Rev."},{"key":"1096_CR106","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2507422122","volume":"122","author":"L Jia","year":"2025","unstructured":"Jia, L. et al. Glomerular endothelial cells eliminate nicotinamide adenine dinucleotide to instruct CD103+ T cells in human lupus nephritis. Proc. Natl Acad. Sci. USA 122, e2507422122 (2025).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR107","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-025-67416-x","volume":"17","author":"M Liu","year":"2025","unstructured":"Liu, M. et al. Lactate bridges mesangial cells to the differentiation of follicular helper T cells in lupus nephritis. Nat. Commun. 17, 663 (2025).","journal-title":"Nat. Commun."},{"key":"1096_CR108","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1038\/s41586-024-07907-x","volume":"634","author":"SI Biniaris-Georgallis","year":"2024","unstructured":"Biniaris-Georgallis, S. I. et al. Amplification of autoimmune organ damage by NKp46-activated ILC1s. Nature 634, 952\u2013960 (2024).","journal-title":"Nature"},{"key":"1096_CR109","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.584414","volume":"12","author":"L Hu","year":"2021","unstructured":"Hu, L. et al. Interleukin-22 from type 3 innate lymphoid cells aggravates lupus nephritis by promoting macrophage infiltration in lupus-prone mice. Front. Immunol. 12, 584414 (2021).","journal-title":"Front. Immunol."},{"key":"1096_CR110","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-024-54516-3","volume":"15","author":"C Corkish","year":"2024","unstructured":"Corkish, C., Aguiar, C. F. & Finlay, D. K. Approaches to investigate tissue-resident innate lymphocytes metabolism at the single-cell level. Nat. Commun. 15, 10424 (2024).","journal-title":"Nat. Commun."},{"key":"1096_CR111","doi-asserted-by":"publisher","DOI":"10.1186\/ar2541","volume":"10","author":"PS Reddy","year":"2008","unstructured":"Reddy, P. S. et al. Mapping similarities in mTOR pathway perturbations in mouse lupus nephritis models and human lupus nephritis. Arthritis Res. Ther. 10, R127 (2008).","journal-title":"Arthritis Res. Ther."},{"key":"1096_CR112","doi-asserted-by":"publisher","first-page":"825","DOI":"10.2215\/CJN.05780616","volume":"12","author":"S Almaani","year":"2017","unstructured":"Almaani, S., Meara, A. & Rovin, B. H. Update on lupus nephritis. Clin. J. Am. Soc. Nephrol. 12, 825\u2013835 (2017).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1096_CR113","first-page":"48","volume":"19","author":"MP Madaio","year":"1999","unstructured":"Madaio, M. P. The role of autoantibodies in the pathogenesis of lupus nephritis. Semin. Nephrol. 19, 48\u201356 (1999).","journal-title":"Semin. Nephrol."},{"key":"1096_CR114","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/nrrheum.2015.159","volume":"12","author":"A Davidson","year":"2016","unstructured":"Davidson, A. What is damaging the kidney in lupus nephritis? Nat. Rev. Rheumatol. 12, 143\u2013153 (2016).","journal-title":"Nat. Rev. Rheumatol."},{"key":"1096_CR115","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR116","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1042\/CS20160421","volume":"131","author":"S Yung","year":"2017","unstructured":"Yung, S. et al. Binding of anti-dsDNA antibodies to proximal tubular epithelial cells contributes to renal tubulointerstitial inflammation. Clin. Sci. 131, 49\u201367 (2017).","journal-title":"Clin. Sci."},{"key":"1096_CR117","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1016\/j.jaut.2015.01.008","volume":"58","author":"S Yung","year":"2015","unstructured":"Yung, S. et al. Anti-dsDNA antibody induces soluble fibronectin secretion by proximal renal tubular epithelial cells and downstream increase of TGF-\u03b21 and collagen synthesis. J. Autoimmun. 58, 111\u2013122 (2015).","journal-title":"J. Autoimmun."},{"key":"1096_CR118","doi-asserted-by":"publisher","first-page":"568","DOI":"10.1016\/j.kint.2017.09.033","volume":"93","author":"BC Liu","year":"2018","unstructured":"Liu, B. C., Tang, T. T., Lv, L. L. & Lan, H. Y. Renal tubule injury: a driving force toward chronic kidney disease. Kidney Int. 93, 568\u2013579 (2018).","journal-title":"Kidney Int."},{"key":"1096_CR119","doi-asserted-by":"publisher","first-page":"802","DOI":"10.1681\/ASN.2010050510","volume":"22","author":"AC Chung","year":"2011","unstructured":"Chung, A. C. & Lan, H. Y. Chemokines in renal injury. J. Am. Soc. Nephrol. 22, 802\u2013809 (2011).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR120","doi-asserted-by":"publisher","first-page":"F1020","DOI":"10.1152\/ajprenal.00291.2001","volume":"282","author":"H Li","year":"2002","unstructured":"Li, H. & Nord, E. P. CD40 ligation stimulates MCP-1 and IL-8 production, TRAF6 recruitment, and MAPK activation in proximal tubule cells. Am. J. Physiol. Ren. Physiol 282, F1020\u2013F1033 (2002).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1096_CR121","doi-asserted-by":"publisher","first-page":"1231","DOI":"10.1161\/CIRCRESAHA.116.302855","volume":"116","author":"G Eelen","year":"2015","unstructured":"Eelen, G., de Zeeuw, P., Simons, M. & Carmeliet, P. Endothelial cell metabolism in normal and diseased vasculature. Circ. Res. 116, 1231\u20131244 (2015).","journal-title":"Circ. Res."},{"key":"1096_CR122","doi-asserted-by":"publisher","first-page":"2109","DOI":"10.1016\/j.biocel.2013.06.013","volume":"45","author":"T Imasawa","year":"2013","unstructured":"Imasawa, T. & Rossignol, R. Podocyte energy metabolism and glomerular diseases. Int. J. Biochem. Cell Biol. 45, 2109\u20132118 (2013).","journal-title":"Int. J. Biochem. Cell Biol."},{"key":"1096_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/srep18575","volume":"5","author":"S Ozawa","year":"2015","unstructured":"Ozawa, S. et al. Glycolysis, but not mitochondria, responsible for intracellular ATP distribution in cortical area of podocytes. Sci. Rep. 5, 18575 (2015).","journal-title":"Sci. Rep."},{"key":"1096_CR124","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.127395","volume":"4","author":"M Kono","year":"2019","unstructured":"Kono, M. et al. Pyruvate kinase M2 is requisite for Th1 and Th17 differentiation. JCI Insight 4, e127395 (2019).","journal-title":"JCI Insight"},{"key":"1096_CR125","doi-asserted-by":"publisher","DOI":"10.1126\/sciadv.adc9657","volume":"8","author":"M Scherlinger","year":"2022","unstructured":"Scherlinger, M. et al. Phosphofructokinase P fine-tunes T regulatory cell metabolism, function, and stability in systemic autoimmunity. Sci. Adv. 8, eadc9657 (2022).","journal-title":"Sci. Adv."},{"key":"1096_CR126","doi-asserted-by":"publisher","first-page":"3341","DOI":"10.1007\/s12013-025-01714-5","volume":"83","author":"J Bao","year":"2025","unstructured":"Bao, J. et al. sPLA2-IB and PLA2R mediate aberrant glucose metabolism in podocytes via hyperactivation of the mTOR\/HIF-1\u03b1 pathway. Cell Biochem. Biophys. 83, 3341\u20133351 (2025).","journal-title":"Cell Biochem. Biophys."},{"key":"1096_CR127","doi-asserted-by":"publisher","first-page":"1251","DOI":"10.1038\/sj.ki.5001664","volume":"70","author":"S Beck","year":"2006","unstructured":"Beck, S. et al. Upregulation of group IB secreted phospholipase A2 and its M-type receptor in rat ANTI-THY-1 glomerulonephritis. Kidney Int. 70, 1251\u20131260 (2006).","journal-title":"Kidney Int."},{"key":"1096_CR128","doi-asserted-by":"publisher","DOI":"10.1096\/fj.202001143R","volume":"35","author":"L Yang","year":"2021","unstructured":"Yang, L. et al. sPLA2-IB and PLA2R mediate insufficient autophagy and contribute to podocyte injury in idiopathic membranous nephropathy by activation of the p38MAPK\/mTOR\/ULK1(ser757) signaling pathway. FASEB J. 35, e21170 (2021).","journal-title":"FASEB J."},{"key":"1096_CR129","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.155260","volume":"7","author":"J Fu","year":"2022","unstructured":"Fu, J. et al. Regeneration of glomerular metabolism and function by podocyte pyruvate kinase M2 in diabetic nephropathy. JCI Insight 7, e155260 (2022).","journal-title":"JCI Insight"},{"key":"1096_CR130","doi-asserted-by":"publisher","DOI":"10.1186\/s13578-019-0317-8","volume":"9","author":"Z Zhang","year":"2019","unstructured":"Zhang, Z. et al. PKM2, function and expression and regulation. Cell Biosci. 9, 52 (2019).","journal-title":"Cell Biosci."},{"key":"1096_CR131","doi-asserted-by":"publisher","first-page":"1179","DOI":"10.1681\/ASN.2008050549","volume":"20","author":"D Schl\u00f6ndorff","year":"2009","unstructured":"Schl\u00f6ndorff, D. & Banas, B. The mesangial cell revisited: no cell is an island. J. Am. Soc. Nephrol. 20, 1179\u20131187 (2009).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR132","doi-asserted-by":"publisher","DOI":"10.1007\/s11926-021-01048-0","volume":"23","author":"TK Nowling","year":"2022","unstructured":"Nowling, T. K. Mesangial cells in lupus nephritis. Curr. Rheumatol. Rep. 23, 83 (2022).","journal-title":"Curr. Rheumatol. Rep."},{"key":"1096_CR133","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.190838","volume":"11","author":"E Liu","year":"2025","unstructured":"Liu, E. et al. Lactate programs PBX1 lactylation and mesangial proliferation in lupus nephritis. JCI Insight 11, e190838 (2025).","journal-title":"JCI Insight"},{"key":"1096_CR134","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-023-00672-z","volume":"29","author":"H Qi","year":"2023","unstructured":"Qi, H., Xu, L. & Liu, Q. Knockdown of DEC2 expression inhibits the proliferation of mesangial cells through suppressed glycolysis and p38 MAPK\/Erk pathway in lupus nephritis. Mol. Med. 29, 99 (2023).","journal-title":"Mol. Med."},{"key":"1096_CR135","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1681\/ASN.2014111067","volume":"26","author":"JW Lee","year":"2015","unstructured":"Lee, J. W., Chou, C. L. & Knepper, M. A. Deep sequencing in microdissected renal tubules identifies nephron segment-specific transcriptomes. J. Am. Soc. Nephrol. 26, 2669\u20132677 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR136","doi-asserted-by":"publisher","first-page":"355","DOI":"10.34067\/KID.0004772020","volume":"2","author":"JA Schaub","year":"2021","unstructured":"Schaub, J. A., Venkatachalam, M. A. & Weinberg, J. M. Proximal tubular oxidative metabolism in acute kidney injury and the transition to CKD. Kidney360 2, 355\u2013364 (2021).","journal-title":"Kidney360"},{"key":"1096_CR137","doi-asserted-by":"publisher","first-page":"819","DOI":"10.2337\/db18-0090","volume":"68","author":"C Kruger","year":"2019","unstructured":"Kruger, C. et al. Proximal tubular cell-specific ablation of carnitine acetyltransferase causes tubular disease and secondary glomerulosclerosis. Diabetes 68, 819\u2013831 (2019).","journal-title":"Diabetes"},{"key":"1096_CR138","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1172\/JCI113380","volume":"81","author":"MA Venkatachalam","year":"1988","unstructured":"Venkatachalam, M. A., Patel, Y. J., Kreisberg, J. I. & Weinberg, J. M. Energy thresholds that determine membrane integrity and injury in a renal epithelial cell line (LLC-PK1). Relationships to phospholipid degradation and unesterified fatty acid accumulation. J. Clin. Invest. 81, 745\u2013758 (1988).","journal-title":"J. Clin. Invest."},{"key":"1096_CR139","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1038\/ki.1984.143","volume":"26","author":"WG Guder","year":"1984","unstructured":"Guder, W. G. & Ross, B. D. Enzyme distribution along the nephron. Kidney Int. 26, 101\u2013111 (1984).","journal-title":"Kidney Int."},{"key":"1096_CR140","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1159\/000472720","volume":"42","author":"H Shi","year":"2017","unstructured":"Shi, H. et al. Detection of renal hypoxia in lupus nephritis using blood oxygen level-dependent MR imaging: a multiple correspondence analysis. Kidney Blood Press. Res. 42, 123\u2013135 (2017).","journal-title":"Kidney Blood Press. Res."},{"key":"1096_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-36432-0","volume":"14","author":"NK Talari","year":"2023","unstructured":"Talari, N. K. et al. Lipid-droplet associated mitochondria promote fatty-acid oxidation through a distinct bioenergetic pattern in male Wistar rats. Nat. Commun. 14, 766 (2023).","journal-title":"Nat. Commun."},{"key":"1096_CR142","doi-asserted-by":"publisher","first-page":"1402","DOI":"10.1681\/ASN.2014050508","volume":"26","author":"TK Nowling","year":"2015","unstructured":"Nowling, T. K. et al. Renal glycosphingolipid metabolism is dysfunctional in lupus nephritis. J. Am. Soc. Nephrol. 26, 1402\u20131413 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR143","doi-asserted-by":"publisher","first-page":"F204","DOI":"10.1152\/ajprenal.00150.2015","volume":"309","author":"M Subathra","year":"2015","unstructured":"Subathra, M. et al. Kidney glycosphingolipids are elevated early in diabetic nephropathy and mediate hypertrophy of mesangial cells. Am. J. Physiol. Ren. Physiol 309, F204\u2013F215 (2015).","journal-title":"Am. J. Physiol. Ren. Physiol"},{"key":"1096_CR144","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1038\/nm.2171","volume":"16","author":"TA Natoli","year":"2010","unstructured":"Natoli, T. A. et al. Inhibition of glucosylceramide accumulation results in effective blockade of polycystic kidney disease in mouse models. Nat. Med. 16, 788\u2013792 (2010).","journal-title":"Nat. Med."},{"key":"1096_CR145","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/j.celrep.2017.09.021","volume":"21","author":"BS Kim","year":"2017","unstructured":"Kim, B. S. et al. Generation of ROR\u03b3t+ antigen-specific T regulatory 17 cells from Foxp3+ precursors in autoimmunity. Cell Rep. 21, 195\u2013207 (2017).","journal-title":"Cell Rep."},{"key":"1096_CR146","doi-asserted-by":"publisher","DOI":"10.3390\/metabo11030142","volume":"11","author":"C Hu","year":"2021","unstructured":"Hu, C. et al. Lipidomics revealed aberrant metabolism of lipids including FAHFAs in renal tissue in the progression of lupus nephritis in a murine model. Metabolites 11, 142 (2021).","journal-title":"Metabolites"},{"key":"1096_CR147","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.161783","volume":"7","author":"A Rinaldi","year":"2022","unstructured":"Rinaldi, A. et al. Impaired fatty acid metabolism perpetuates lipotoxicity along the transition to chronic kidney injury. JCI Insight 7, e161783 (2022).","journal-title":"JCI Insight"},{"key":"1096_CR148","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/nrneph.2017.155","volume":"14","author":"S Agrawal","year":"2018","unstructured":"Agrawal, S., Zaritsky, J. J., Fornoni, A. & Smoyer, W. E. Dyslipidaemia in nephrotic syndrome: mechanisms and treatment. Nat. Rev. Nephrol. 14, 57\u201370 (2018).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR149","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2022.109213","volume":"248","author":"AA Alli","year":"2023","unstructured":"Alli, A. A. et al. Kidney tubular epithelial cell ferroptosis links glomerular injury to tubulointerstitial pathology in lupus nephritis. Clin. Immunol. 248, 109213 (2023).","journal-title":"Clin. Immunol."},{"key":"1096_CR150","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1126\/science.1059817","volume":"292","author":"M Ivan","year":"2001","unstructured":"Ivan, M. et al. HIF\u03b1 targeted for VHL-mediated destruction by proline hydroxylation: implications for O2 sensing. Science 292, 464\u2013468 (2001).","journal-title":"Science"},{"key":"1096_CR151","doi-asserted-by":"publisher","first-page":"113","DOI":"10.1016\/S0304-4165(02)00497-X","volume":"1619","author":"DM Templeton","year":"2003","unstructured":"Templeton, D. M. & Liu, Y. Genetic regulation of cell function in response to iron overload or chelation. Biochim. Biophys. Acta 1619, 113\u2013124 (2003).","journal-title":"Biochim. Biophys. Acta"},{"key":"1096_CR152","doi-asserted-by":"publisher","first-page":"343","DOI":"10.1007\/s10534-019-00191-7","volume":"32","author":"TA Rouault","year":"2019","unstructured":"Rouault, T. A. The indispensable role of mammalian iron sulfur proteins in function and regulation of multiple diverse metabolic pathways. Biometals 32, 343\u2013353 (2019).","journal-title":"Biometals"},{"key":"1096_CR153","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1182\/blood.V64.3.748.748","volume":"64","author":"HM Lederman","year":"1984","unstructured":"Lederman, H. M., Cohen, A., Lee, J. W., Freedman, M. H. & Gelfand, E. W. Deferoxamine: a reversible S-phase inhibitor of human lymphocyte proliferation. Blood 64, 748\u2013753 (1984).","journal-title":"Blood"},{"key":"1096_CR154","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1016\/0378-4274(95)03532-X","volume":"82-83","author":"CC Winterbourn","year":"1995","unstructured":"Winterbourn, C. C. Toxicity of iron and hydrogen peroxide: the Fenton reaction. Toxicol. Lett. 82-83, 969\u2013974 (1995).","journal-title":"Toxicol. Lett."},{"key":"1096_CR155","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1007\/BF02535600","volume":"23","author":"KM Schaich","year":"1988","unstructured":"Schaich, K. M. & Borg, D. C. Fenton reactions in lipid phases. Lipids 23, 570\u2013579 (1988).","journal-title":"Lipids"},{"key":"1096_CR156","doi-asserted-by":"publisher","first-page":"957","DOI":"10.1080\/1744666X.2021.1953981","volume":"17","author":"C Wincup","year":"2021","unstructured":"Wincup, C., Sawford, N. & Rahman, A. Pathological mechanisms of abnormal iron metabolism and mitochondrial dysfunction in systemic lupus erythematosus. Expert. Rev. Clin. Immunol. 17, 957\u2013967 (2021).","journal-title":"Expert. Rev. Clin. Immunol."},{"key":"1096_CR157","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214248","volume":"14","author":"MA Atkinson","year":"2019","unstructured":"Atkinson, M. A., Joo, S. & Sule, S. Hepcidin and arterial stiffness in children with systemic lupus erythematosus and lupus nephritis: a cross-sectional study. PLoS ONE 14, e0214248 (2019).","journal-title":"PLoS ONE"},{"key":"1096_CR158","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-13029-4","volume":"7","author":"ES Marks","year":"2017","unstructured":"Marks, E. S. et al. Renal iron accumulation occurs in lupus nephritis and iron chelation delays the onset of albuminuria. Sci. Rep. 7, 12821 (2017).","journal-title":"Sci. Rep."},{"key":"1096_CR159","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020723","volume":"22","author":"P W\u00f3jcik","year":"2021","unstructured":"W\u00f3jcik, P., G\u0119gotek, A., \u017darkovi\u0107, N. & Skrzydlewska, E. Oxidative stress and lipid mediators modulate immune cell functions in autoimmune diseases. Int. J. Mol. Sci. 22, 723 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1096_CR160","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2023.1171318","volume":"14","author":"Q Cheng","year":"2023","unstructured":"Cheng, Q. et al. Ferroptosis of CD163+ tissue-infiltrating macrophages and CD10+ PC+ epithelial cells in lupus nephritis. Front. Immunol. 14, 1171318 (2023).","journal-title":"Front. Immunol."},{"key":"1096_CR161","doi-asserted-by":"publisher","first-page":"799","DOI":"10.2174\/1566524022666220525144630","volume":"23","author":"B Yang","year":"2023","unstructured":"Yang, B., Hou, S., Huang, S., Li, H. & Li, Y. Ferroptosis inhibitor regulates the disease progression of systematic lupus erythematosus mice model through Th1\/Th2 ratio. Curr. Mol. Med. 23, 799\u2013807 (2023).","journal-title":"Curr. Mol. Med."},{"key":"1096_CR162","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1038\/s41590-021-00993-3","volume":"22","author":"P Li","year":"2021","unstructured":"Li, P. et al. Glutathione peroxidase 4-regulated neutrophil ferroptosis induces systemic autoimmunity. Nat. Immunol. 22, 1107\u20131117 (2021).","journal-title":"Nat. Immunol."},{"key":"1096_CR163","doi-asserted-by":"publisher","DOI":"10.1016\/j.clim.2023.109778","volume":"256","author":"Q Chen","year":"2023","unstructured":"Chen, Q. et al. The role of B-cell ferroptosis in the pathogenesis of systemic lupus erythematosus. Clin. Immunol. 256, 109778 (2023).","journal-title":"Clin. Immunol."},{"key":"1096_CR164","first-page":"1066","volume":"81","author":"J Stiban","year":"2016","unstructured":"Stiban, J., So, M. & Kaguni, L. S. Iron-sulfur clusters in mitochondrial metabolism: multifaceted roles of a simple cofactor. Biochemistry 81, 1066\u20131080 (2016).","journal-title":"Biochemistry"},{"key":"1096_CR165","doi-asserted-by":"publisher","first-page":"531","DOI":"10.15698\/mic2019.12.700","volume":"6","author":"J Telser","year":"2019","unstructured":"Telser, J. et al. Metabolic reprogramming of Salmonella infected macrophages and its modulation by iron availability and the mTOR pathway. Microb. Cell 6, 531\u2013543 (2019).","journal-title":"Microb. Cell"},{"key":"1096_CR166","doi-asserted-by":"publisher","first-page":"80","DOI":"10.2337\/db10-0593","volume":"60","author":"J Huang","year":"2011","unstructured":"Huang, J. et al. Iron overload and diabetes risk: a shift from glucose to fatty acid oxidation and increased hepatic glucose production in a mouse model of hereditary hemochromatosis. Diabetes 60, 80\u201387 (2011).","journal-title":"Diabetes"},{"key":"1096_CR167","doi-asserted-by":"publisher","first-page":"498","DOI":"10.1016\/j.celrep.2019.06.039","volume":"28","author":"M Pereira","year":"2019","unstructured":"Pereira, M. et al. Acute iron deprivation reprograms human macrophage metabolism and reduces inflammation in vivo. Cell Rep. 28, 498\u2013511 (2019).","journal-title":"Cell Rep."},{"key":"1096_CR168","doi-asserted-by":"publisher","first-page":"1060","DOI":"10.1016\/j.cell.2012.03.042","volume":"149","author":"SJ Dixon","year":"2012","unstructured":"Dixon, S. J. et al. Ferroptosis: an iron-dependent form of nonapoptotic cell death. Cell 149, 1060\u20131072 (2012).","journal-title":"Cell"},{"key":"1096_CR169","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1016\/j.bbrc.2016.10.086","volume":"482","author":"MM Gaschler","year":"2017","unstructured":"Gaschler, M. M. & Stockwell, B. R. Lipid peroxidation in cell death. Biochem. Biophys. Res. Commun. 482, 419\u2013425 (2017).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"1096_CR170","doi-asserted-by":"publisher","first-page":"1137","DOI":"10.1038\/s41589-019-0408-1","volume":"15","author":"M Conrad","year":"2019","unstructured":"Conrad, M. & Pratt, D. A. The chemical basis of ferroptosis. Nat. Chem. Biol. 15, 1137\u20131147 (2019).","journal-title":"Nat. Chem. Biol."},{"key":"1096_CR171","doi-asserted-by":"publisher","first-page":"231","DOI":"10.1016\/j.freeradbiomed.2019.12.028","volume":"147","author":"VE Kagan","year":"2020","unstructured":"Kagan, V. E. et al. Redox phospholipidomics of enzymatically generated oxygenated phospholipids as specific signals of programmed cell death. Free Radic. Biol. Med. 147, 231\u2013241 (2020).","journal-title":"Free Radic. Biol. Med."},{"key":"1096_CR172","doi-asserted-by":"publisher","first-page":"1127","DOI":"10.1038\/s41590-021-00996-0","volume":"22","author":"Y Yao","year":"2021","unstructured":"Yao, Y. et al. Selenium-GPX4 axis protects follicular helper T cells from ferroptosis. Nat. Immunol. 22, 1127\u20131139 (2021).","journal-title":"Nat. Immunol."},{"key":"1096_CR173","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/s41581-025-01025-1","volume":"22","author":"EM Scheidereit","year":"2025","unstructured":"Scheidereit, E. M., Mavrommatis, L. & Kuppe, C. Cell-cell crosstalk in kidney health and disease. Nat. Rev. Nephrol. 22, 199\u2013214 (2025).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR174","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1146\/annurev-physiol-021115-105412","volume":"78","author":"CS Bartlett","year":"2016","unstructured":"Bartlett, C. S., Jeansson, M. & Quaggin, S. E. Vascular growth factors and glomerular disease. Annu. Rev. Physiol. 78, 437\u2013461 (2016).","journal-title":"Annu. Rev. Physiol."},{"key":"1096_CR175","doi-asserted-by":"publisher","first-page":"1847","DOI":"10.1242\/dev.01080","volume":"131","author":"M Bjarnegard","year":"2004","unstructured":"Bjarnegard, M. et al. Endothelium-specific ablation of PDGFB leads to pericyte loss and glomerular, cardiac and placental abnormalities. Development 131, 1847\u20131857 (2004).","journal-title":"Development"},{"key":"1096_CR176","doi-asserted-by":"publisher","first-page":"206","DOI":"10.1038\/s41581-023-00786-x","volume":"20","author":"GC Tsokos","year":"2024","unstructured":"Tsokos, G. C. et al. The immunoregulatory roles of non-haematopoietic cells in the kidney. Nat. Rev. Nephrol. 20, 206\u2013217 (2024).","journal-title":"Nat. Rev. Nephrol."},{"key":"1096_CR177","doi-asserted-by":"publisher","first-page":"238","DOI":"10.1016\/j.kint.2020.05.051","volume":"99","author":"D Abdirama","year":"2021","unstructured":"Abdirama, D. et al. Nuclear antigen-reactive CD4+ T cells expand in active systemic lupus erythematosus, produce effector cytokines, and invade the kidneys. Kidney Int. 99, 238\u2013246 (2021).","journal-title":"Kidney Int."},{"key":"1096_CR178","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2025.112742","volume":"28","author":"V Poindessous","year":"2025","unstructured":"Poindessous, V. et al. Interferon gamma induced-ACSL5 shapes the lipidome of kidney tubular cells. iScience 28, 112742 (2025).","journal-title":"iScience"},{"key":"1096_CR179","doi-asserted-by":"publisher","first-page":"176","DOI":"10.1016\/j.amjms.2020.10.003","volume":"361","author":"A Rajasekaran","year":"2021","unstructured":"Rajasekaran, A., Julian, B. A. & Rizk, D. V. IgA nephropathy: an interesting autoimmune kidney disease. Am. J. Med. Sci. 361, 176\u2013194 (2021).","journal-title":"Am. J. Med. Sci."},{"key":"1096_CR180","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/s41423-024-01233-y","volume":"22","author":"X Meng","year":"2025","unstructured":"Meng, X. et al. Metabolic rewiring controlled by HIF-1\u03b1 tunes IgA-producing B-cell differentiation and intestinal inflammation. Cell Mol. Immunol. 22, 54\u201367 (2025).","journal-title":"Cell Mol. Immunol."},{"key":"1096_CR181","doi-asserted-by":"publisher","DOI":"10.1126\/scitranslmed.adl6149","volume":"16","author":"PJ Gleeson","year":"2024","unstructured":"Gleeson, P. J. et al. The gut microbiota posttranslationally modifies IgA1 in autoimmune glomerulonephritis. Sci. Transl. Med. 16, eadl6149 (2024).","journal-title":"Sci. Transl. Med."},{"key":"1096_CR182","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.chom.2016.07.001","volume":"20","author":"M Kim","year":"2016","unstructured":"Kim, M., Qie, Y., Park, J. & Kim, C. H. Gut microbial metabolites fuel host antibody responses. Cell Host Microbe 20, 202\u2013214 (2016).","journal-title":"Cell Host Microbe"},{"key":"1096_CR183","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-13629-5","volume":"15","author":"A Popova","year":"2025","unstructured":"Popova, A. et al. Reduced butyrate-producing bacteria and altered metabolic pathways in the gut microbiome of immunoglobulin A nephropathy patients. Sci. Rep. 15, 28011 (2025).","journal-title":"Sci. Rep."},{"key":"1096_CR184","doi-asserted-by":"publisher","first-page":"43","DOI":"10.4103\/ejpi.EJPI-D-24-00095","volume":"68","author":"H Zou","year":"2025","unstructured":"Zou, H. et al. CircRNA-0013747 promotes mesangial cell proliferation in immunoglobulin A nephropathy through modulation of the Warburg effect. J. Physiol. Investig. 68, 43\u201356 (2025).","journal-title":"J. Physiol. Investig."},{"key":"1096_CR185","doi-asserted-by":"publisher","DOI":"10.1016\/j.intimp.2024.112748","volume":"140","author":"J Qing","year":"2024","unstructured":"Qing, J. et al. Exploring macrophage heterogeneity in IgA nephropathy: mechanisms of renal impairment and current therapeutic targets. Int. Immunopharmacol. 140, 112748 (2024).","journal-title":"Int. Immunopharmacol."},{"key":"1096_CR186","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1053\/j.ajkd.2019.04.031","volume":"75","author":"D Geetha","year":"2020","unstructured":"Geetha, D. & Jefferson, J. A. ANCA-associated vasculitis: core curriculum 2020. Am. J. Kidney Dis. 75, 124\u2013137 (2020).","journal-title":"Am. J. Kidney Dis."},{"key":"1096_CR187","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.789740","volume":"12","author":"Y Shimojima","year":"2021","unstructured":"Shimojima, Y. et al. Oxidative stress promotes instability of regulatory T cells in antineutrophil cytoplasmic antibody-associated vasculitis. Front. Immunol. 12, 789740 (2021).","journal-title":"Front. Immunol."},{"key":"1096_CR188","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2020.00553","volume":"7","author":"EC O\u2019Brien","year":"2020","unstructured":"O\u2019Brien, E. C. et al. Pro-inflammatory stimulation of monocytes by ANCA is linked to changes in cellular metabolism. Front. Med. 7, 553 (2020).","journal-title":"Front. Med."},{"key":"1096_CR189","doi-asserted-by":"publisher","first-page":"1908","DOI":"10.1016\/j.ajpath.2017.05.003","volume":"187","author":"A Rousselle","year":"2017","unstructured":"Rousselle, A., Kettritz, R. & Schreiber, A. Monocytes promote crescent formation in anti-myeloperoxidase antibody-induced glomerulonephritis. Am. J. Pathol. 187, 1908\u20131915 (2017).","journal-title":"Am. J. Pathol."},{"key":"1096_CR190","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1681\/ASN.20223311S1481a","volume":"33","author":"A Rousselle","year":"2022","unstructured":"Rousselle, A., Lodka, D., Kling, L., Kettritz, R. & Schreiber, A. Endothelial cell ferroptosis promotes renal damage in ANCA-induced glomerulonephritis. J. Am. Soc. Nephrol. 33, 481\u2013481 (2022).","journal-title":"J. Am. Soc. Nephrol."},{"key":"1096_CR191","doi-asserted-by":"publisher","first-page":"641","DOI":"10.1016\/j.cell.2020.06.014","volume":"182","author":"L Wu","year":"2020","unstructured":"Wu, L. et al. Niche-selective inhibition of pathogenic Th17 cells by targeting metabolic redundancy. Cell 182, 641\u2013654 (2020).","journal-title":"Cell"},{"key":"1096_CR192","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.166076","volume":"8","author":"AJ Little","year":"2023","unstructured":"Little, A. J. et al. HIF-1 regulates pathogenic cytotoxic T cells in lupus skin disease. JCI Insight 8, e166076 (2023).","journal-title":"JCI Insight"},{"key":"1096_CR193","doi-asserted-by":"publisher","DOI":"10.1186\/s10020-024-00866-z","volume":"30","author":"L Zhao","year":"2024","unstructured":"Zhao, L. et al. Regulation of macrophage polarization by targeted metabolic reprogramming for the treatment of lupus nephritis. Mol. Med. 30, 96 (2024).","journal-title":"Mol. Med."},{"key":"1096_CR194","doi-asserted-by":"publisher","DOI":"10.1136\/lupus-2020-000387","volume":"7","author":"KA Fortner","year":"2020","unstructured":"Fortner, K. A. et al. Targeting mitochondrial oxidative stress with MitoQ reduces NET formation and kidney disease in lupus-prone MRL-lpr mice. Lupus Sci. Med. 7, e000387 (2020).","journal-title":"Lupus Sci. Med."},{"key":"1096_CR195","doi-asserted-by":"publisher","first-page":"309","DOI":"10.2215\/CJN.0000000000000297","volume":"19","author":"H Menn-Josephy","year":"2024","unstructured":"Menn-Josephy, H., Hodge, L. S., Birardi, V. & Leher, H. Efficacy of voclosporin in proliferative lupus nephritis with high levels of proteinuria. Clin. J. Am. Soc. Nephrol. 19, 309\u2013318 (2024).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"1096_CR196","doi-asserted-by":"publisher","first-page":"2559","DOI":"10.1016\/j.ekir.2024.04.069","volume":"9","author":"F Afshinnia","year":"2024","unstructured":"Afshinnia, F. et al. Voclosporin induces systemic lipidomic alterations: implications for lupus nephritis remission. Kidney Int. Rep. 9, 2559\u20132562 (2024).","journal-title":"Kidney Int. Rep."},{"key":"1096_CR197","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/MNH.0b013e32833aa4ac","volume":"19","author":"IA Bobulescu","year":"2010","unstructured":"Bobulescu, I. A. Renal lipid metabolism and lipotoxicity. Curr. Opin. Nephrol. Hypertens. 19, 393\u2013402 (2010).","journal-title":"Curr. Opin. Nephrol. Hypertens."},{"key":"1096_CR198","doi-asserted-by":"publisher","first-page":"1328","DOI":"10.1136\/ard-2023-224242","volume":"82","author":"XY Zhao","year":"2023","unstructured":"Zhao, X. Y. et al. SGLT2 inhibitors alleviated podocyte damage in lupus nephritis by decreasing inflammation and enhancing autophagy. Ann. Rheum. Dis. 82, 1328\u20131340 (2023).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR199","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/j.kint.2025.09.026","volume":"109","author":"J Vilardell-Vil\u00e0","year":"2025","unstructured":"Vilardell-Vil\u00e0, J. et al. Sodium glucose cotransporter 2 inhibition does not improve active lupus nephritis in MRLlpr\/lpr mice. Kidney Int. 109, 211\u2013216 (2025).","journal-title":"Kidney Int."},{"key":"1096_CR200","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2024.16578","volume":"7","author":"FS Yen","year":"2024","unstructured":"Yen, F. S., Wang, S. I., Hsu, C. C., Hwu, C. M. & Wei, J. C. Sodium-glucose cotransporter-2 inhibitors and nephritis among patients with systemic lupus erythematosus. JAMA Netw. Open. 7, e2416578 (2024).","journal-title":"JAMA Netw. Open."},{"key":"1096_CR201","doi-asserted-by":"publisher","DOI":"10.1016\/j.semarthrit.2025.152746","volume":"73","author":"I Sagy","year":"2025","unstructured":"Sagy, I. et al. Kidney outcomes of systemic lupus erythematosus patients treated with SGLT2 inhibitors: a national cohort study. Semin. Arthritis Rheum. 73, 152746 (2025).","journal-title":"Semin. Arthritis Rheum."},{"key":"1096_CR202","doi-asserted-by":"publisher","first-page":"632","DOI":"10.1161\/CIRCRESAHA.124.324823","volume":"135","author":"JH Berger","year":"2024","unstructured":"Berger, J. H. et al. SGLT2 inhibitors act independently of SGLT2 to confer benefit for HFrEF in mice. Circ. Res. 135, 632\u2013634 (2024).","journal-title":"Circ. Res."},{"key":"1096_CR203","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2023.101334","volume":"4","author":"Q Wu","year":"2023","unstructured":"Wu, Q. et al. Dapagliflozin protects against chronic heart failure in mice by inhibiting macrophage-mediated inflammation, independent of SGLT2. Cell Rep. Med. 4, 101334 (2023).","journal-title":"Cell Rep. Med."},{"key":"1096_CR204","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.immuni.2020.08.012","volume":"53","author":"A Lercher","year":"2020","unstructured":"Lercher, A., Baazim, H. & Bergthaler, A. Systemic immunometabolism: challenges and opportunities. Immunity 53, 496\u2013509 (2020).","journal-title":"Immunity"},{"key":"1096_CR205","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2024.102486","volume":"91","author":"FQ Zhang","year":"2024","unstructured":"Zhang, F. Q., Chen, J. & Fan, H. Eating for immunity: how diet shapes our defenses. Curr. Opin. Immunol. 91, 102486 (2024).","journal-title":"Curr. Opin. Immunol."},{"key":"1096_CR206","doi-asserted-by":"publisher","DOI":"10.1210\/endocr\/bqac067","volume":"163","author":"M Terrell","year":"2022","unstructured":"Terrell, M. & Morel, L. The intersection of cellular and systemic metabolism: metabolic syndrome in systemic lupus erythematosus. Endocrinol 163, bqac067 (2022).","journal-title":"Endocrinol"},{"key":"1096_CR207","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1002\/acr.25395","volume":"77","author":"S Rossato","year":"2025","unstructured":"Rossato, S. et al. Ultraprocessed food intake and risk of systemic lupus erythematosus among women observed in the Nurses\u2019 Health Study cohorts. Arthritis Care Res. 77, 50\u201360 (2025).","journal-title":"Arthritis Care Res."},{"key":"1096_CR208","doi-asserted-by":"publisher","first-page":"5767","DOI":"10.1093\/rheumatology\/keaf348","volume":"64","author":"ZC Song","year":"2025","unstructured":"Song, Z. C. et al. Potential protective role of high Mediterranean diet adherence for systemic lupus erythematosus: mediation by liver and kidney function biomarkers in the UK Biobank cohort. Rheumatology 64, 5767\u20135775 (2025).","journal-title":"Rheumatology"},{"key":"1096_CR209","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22126493","volume":"22","author":"E Nemeth","year":"2021","unstructured":"Nemeth, E. & Ganz, T. Hepcidin-ferroportin interaction controls systemic iron homeostasis. Int. J. Mol. Sci. 22, 6493 (2021).","journal-title":"Int. J. Mol. Sci."},{"key":"1096_CR210","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2021.643686","volume":"8","author":"E Wlazlo","year":"2021","unstructured":"Wlazlo, E., Mehrad, B., Morel, L. & Scindia, Y. Iron metabolism: An under investigated driver of renal pathology in lupus nephritis. Front. Med. 8, 643686 (2021).","journal-title":"Front. Med."},{"key":"1096_CR211","doi-asserted-by":"publisher","first-page":"100","DOI":"10.1016\/j.kint.2020.01.025","volume":"98","author":"Y Scindia","year":"2020","unstructured":"Scindia, Y. et al. Modulation of iron homeostasis with hepcidin ameliorates spontaneous murine lupus nephritis. Kidney Int. 98, 100\u2013115 (2020).","journal-title":"Kidney Int."},{"key":"1096_CR212","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1016\/j.ceb.2014.03.008","volume":"29","author":"F Wilfling","year":"2014","unstructured":"Wilfling, F., Haas, J. T., Walther, T. C. & Farese, R. V. Jr. Lipid droplet biogenesis. Curr. Opin. Cell Biol. 29, 39\u201345 (2014).","journal-title":"Curr. Opin. Cell Biol."},{"key":"1096_CR213","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.87510.4","volume":"12","author":"J Lin","year":"2023","unstructured":"Lin, J. et al. A positive feedback loop between ZEB2 and ACSL4 regulates lipid metabolism to promote breast cancer metastasis. Elife 12, RP87510 (2023).","journal-title":"Elife"},{"key":"1096_CR214","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1038\/nchembio.2238","volume":"13","author":"VE Kagan","year":"2017","unstructured":"Kagan, V. E. et al. Oxidized arachidonic and adrenic PEs navigate cells to ferroptosis. Nat. Chem. Biol. 13, 81\u201390 (2017).","journal-title":"Nat. Chem. Biol."},{"key":"1096_CR215","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.2218896120","volume":"120","author":"HH Dar","year":"2023","unstructured":"Dar, H. H. et al. Discovering selective antiferroptotic inhibitors of the 15LOX\/PEBP1 complex noninterfering with biosynthesis of lipid mediators. Proc. Natl Acad. Sci. USA 120, e2218896120 (2023).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"1096_CR216","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1021\/acscentsci.7b00028","volume":"3","author":"O Zilka","year":"2017","unstructured":"Zilka, O. et al. On the mechanism of cytoprotection by ferrostatin-1 and liproxstatin-1 and the role of lipid peroxidation in ferroptotic cell death. ACS Cent. Sci. 3, 232\u2013243 (2017).","journal-title":"ACS Cent. Sci."},{"key":"1096_CR217","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1053\/j.ajkd.2025.04.012","volume":"86","author":"J Peng","year":"2025","unstructured":"Peng, J., Zhang, Y., Wang, J., Zhang, H. & Schett, G. Role of chimeric antigen receptor-expressing cell therapy in immune-mediated kidney diseases: a review. Am. J. Kidney Dis. 86, 360\u2013371 (2025).","journal-title":"Am. J. Kidney Dis."},{"key":"1096_CR218","doi-asserted-by":"publisher","first-page":"567","DOI":"10.1056\/NEJMc2107725","volume":"385","author":"D Mougiakakos","year":"2021","unstructured":"Mougiakakos, D. et al. CD19-targeted CAR T cells in refractory systemic lupus erythematosus. N. Engl. J. Med. 385, 567\u2013569 (2021).","journal-title":"N. Engl. J. Med."},{"key":"1096_CR219","doi-asserted-by":"publisher","first-page":"1675","DOI":"10.1016\/j.ard.2025.06.2128","volume":"84","author":"Z Hu","year":"2025","unstructured":"Hu, Z. et al. BCMA-targeted CAR T cell therapy can effectively induce disease remission in refractory lupus nephritis. Ann. Rheum. Dis. 84, 1675\u20131683 (2025).","journal-title":"Ann. Rheum. Dis."},{"key":"1096_CR220","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1038\/s42255-024-01034-7","volume":"6","author":"A Lakhani","year":"2024","unstructured":"Lakhani, A. et al. Extracellular domains of CARs reprogramme T cell metabolism without antigen stimulation. Nat. Metab. 6, 1143\u20131160 (2024).","journal-title":"Nat. Metab."},{"key":"1096_CR221","doi-asserted-by":"publisher","DOI":"10.1172\/jci.insight.177141","volume":"9","author":"R Hatae","year":"2024","unstructured":"Hatae, R. et al. Enhancing CAR-T cell metabolism to overcome hypoxic conditions in the brain tumor microenvironment. JCI Insight 9, e177141 (2024).","journal-title":"JCI Insight"},{"key":"1096_CR222","doi-asserted-by":"publisher","first-page":"1186","DOI":"10.1016\/S0140-6736(18)30485-9","volume":"391","author":"ZW Lai","year":"2018","unstructured":"Lai, Z. W. et al. Sirolimus in patients with clinically active systemic lupus erythematosus resistant to, or intolerant of, conventional medications: a single-arm, open-label, phase 1\/2 trial. Lancet 391, 1186\u20131196 (2018).","journal-title":"Lancet"},{"key":"1096_CR223","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1637436","volume":"16","author":"M Tada","year":"2025","unstructured":"Tada, M. & Kono, M. Metabolites as regulators of autoimmune diseases. Front. Immunol. 16, 1637436 (2025).","journal-title":"Front. Immunol."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01096-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01096-8","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01096-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T12:02:34Z","timestamp":1789560154000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-026-01096-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,6]]},"references-count":223,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["1096"],"URL":"https:\/\/doi.org\/10.1038\/s41581-026-01096-8","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,6]]},"assertion":[{"value":"11 June 2026","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"6 July 2026","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}}]}}